Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $19.3600 (-0.51%) ($18.8000 - $19.7300) on Fri. Oct. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.87% (three month average) | RSI | 36 | Latest Price | $19.3600(-0.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.435% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-9%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.435% (StdDev 2.87%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
1 - 5 Day Possible Target | $8.55(-55.84%) | Resistance Level | $19.83 | 5 Day Moving Average | $18.94(2.22%) | 10 Day Moving Average | $18.97(2.06%) | 20 Day Moving Average | $19.83(-2.37%) | To recent high | -25.5% | To recent low | 7.6% | Market Cap | $2.835b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |